Published Online:7 Jul 2015https://doi.org/10.4155/tde.15.24
Abstract
Iron deficiency anemia is one of the major nutritional deficiency disorders. Iron deficiency anemia occurs due to decreased absorption of iron from diet, chronic blood loss and other associated diseases. The importance of iron and deleterious effects of iron deficiency anemia are discussed briefly in this review followed by the transdermal approaches to deliver iron. Transdermal delivery of iron would be able to overcome the side effects associated with conventional oral and parenteral iron therapy and improves the patient compliance. During preliminary investigations, ferric pyrophosphate and iron dextran were selected as iron sources for transdermal delivery. Different biophysical techniques were explored to assess their efficiency in delivering iron across the skin, and in vivo studies were carried out using anemic rat model. Transdermal iron delivery is a promising approach that could make a huge positive impact on patients suffering with iron deficiency.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1 . Three generations: the past, present, and future of transdermal drug delivery systems. Pharmacon Inc. 2001, 1–22 (2001). www.freece.com/Files/Classroom/ProgramSlides/1be80281-23ef-4687-a334-c79b7200dd19/3%20Gen%20Homestudy%20%28TV%29.pdf.Google Scholar
- 2 . Transdermal delivery takes up once-forbidden compounds, reviving markets and creating formulation opportunities. Pharm. Technol. 31(10), 54–58 (2007).Google Scholar
- 3 . Transdermal drug delivery. Nat. Biotechnol. 26(11), 1261–1268 (2008).• Highlights the importance of transdermal drug delivery systems in modern medicine and discusses the highlights of transdermal drug development systems at various stages in chronological order.Crossref, Medline, CAS, Google Scholar
- 4 . Metals and the skin. Crit. Rev. Toxicol. 23(2), 171–235 (1993).Crossref, Medline, CAS, Google Scholar
- 5 . Individualized treatment for iron-deficiency anemia in adults. Am. J. Med. 121, 943–948 (2008).Crossref, Medline, Google Scholar
- 6 . The role of iron in the immune response to bacterial infection. Immunol. Res. 50(1), 1–9 (2011).Crossref, Medline, CAS, Google Scholar
- 7 . Cellular iron metabolism: mitochondria in the spotlight. Blood 105(5), 1844–1845 (2005).Crossref, Medline, CAS, Google Scholar
- 8 . Guidelines for Adolescent Nutrition Services Center for Leadership, Education and Training in Maternal and Child Nutrition (2015). www.epi.umn.edu/let/pubs/adol_book.shtm.Google Scholar
- 9 . Control of iron deficiency anemia in low- and middle-income countries. Blood 121(14), 2607–2617 (2013).Crossref, Medline, CAS, Google Scholar
- 10 . Diagnosis and management of iron deficiency anemia. Calif. J. Health-Syst. Pharm. 22(2), 5 (2010).Google Scholar
- 11 . Iron deficiency: a concise review. Am. J. Hematol. 78(3), 225–231 (2005).Crossref, Medline, CAS, Google Scholar
- 12 . Parenteral iron therapy options. Am. J. Hematol. 76(1), 74–78 (2004).Crossref, Medline, CAS, Google Scholar
- 13 . Goodman & Gilman's The Pharmacological Basis Of Therapeutics (11th Edition). McGraw-Hill, USA (2006).Google Scholar
- 14 Harrison's Principles of Internal Medicine (16th Edition). McGraw-Hill, USA (2005).Google Scholar
- 15 . Toxicity of parenteral iron dextran therapy. Kidney Int. 55, S119–S124 (1999).Crossref, Google Scholar
- 16 . Radioisotopic studies on percutaneous absorption. I. Absorption of water-soluble substances from hydrophilic and absorption ointments through mouse skin. Chem. Pharm. Bull. 15(10), 1470–1477 (1967).Crossref, Medline, CAS, Google Scholar
- 17 . Transdermal drug delivery. Nat. Biotechnol. 26(11), 1261–1268 (2008).Crossref, Medline, CAS, Google Scholar
- 18 . Breaking the Barrier-Advances in Transdermal Technology. Pharma Tech. 28(46), (2004).Google Scholar
- 19 . Treatment of iron deficiency anemia: Are monomeric iron compounds suitable for parenteral administration? J. Lab. Clin. Med. 136, 371–378 (2000).•• Highlights the importance of noncolloidal iron sources as alternative to colloidal iron compounds for parenteral delivery.Crossref, Medline, CAS, Google Scholar
- 20 . Iron exchange between transferrin molecules mediated by phosphate compounds and other cell metabolites. Biochim. Biophys. Acta. 499, 169–177 (1977).Crossref, Medline, CAS, Google Scholar
- 21 . Complexation in analytical chemistry: a guide for the critical selection of analytical methods based on complexation reactions. In: Chemical analysis: A Series of Monographs on Analytical Chemistry and its Applications. Elving PJ, Kolthoff IM (Eds). Interscience Publishers, NY, USA (1963).Google Scholar
- 22 . Irontophoresis: transdermal delivery of iron by iontophoresis. J. Pharm. Sci. 98(8), 2670–2676 (2009).•• This was the first of its kind in exploring the possibility of transdermal delivery of iron. Iontophoresis was shown to enhance the transdermal iron delivery successfully.Crossref, Medline, CAS, Google Scholar
- 23 . Minimally invasive transdermal delivery of iron–dextran. J. Pharm. Sci. (102), 987–993 (2013).•• Transdermal delivery of iron colloids was investigated for the first time and this article proves that iron dextran can be delivered across microporated skin to achieve therapeutic dose in anemic animal models.Crossref, Medline, CAS, Google Scholar
- 24 . Constant voltage ‘iron'tophoresis. Pharm. Dev. Technol. 6(5), 483–488 (2011).Crossref, Google Scholar
- 25 . Microporation and ‘Iron'tophoresis for treating iron deficiency anemia. Pharm. Res. 30, 889–898 (2013).•• Highlights the significance of transdermal iron delivery of noncolloidal iron to reverse anemic condition in anemic rat models. Iontophoresis along with microneedle pretreatment proved to be a successful technique for transdermal delivery of iron.Crossref, Medline, CAS, Google Scholar
- 26 . Challenges and opportunities in dermal/transdermal delivery. Ther. Deliv. 1(1), 109–131 (2010).Link, CAS, Google Scholar
